Dapagliflozin
NDC 60505-4912, DAPAGLIFLOZIN, tablet, film coated, from Apotex Corp..
- Product NDC
- 60505-4912
- Status
- Listed
- Labeler
- Apotex Corp.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211523
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60505-4912 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DAPAGLIFLOZIN10 mg/1
Pharmacologic classes
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60505-4912-3 | 60505491203 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60505-4912-3) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/bd9766c5-104f-4636-897d-b6c92eb94f18NADAC price for package 60505491203
GET /v1/drugs/nadac/60505491203
Use it
Look up 60505-4912 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60505-4912 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60505-4912. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.